144 related articles for article (PubMed ID: 12852863)
1. Marginal transfer of ReoPro (Abciximab) compared with immunoglobulin G (F105), inulin and water in the perfused human placenta in vitro.
Miller RK; Mace K; Polliotti B; DeRita R; Hall W; Treacy G
Placenta; 2003 Aug; 24(7):727-38. PubMed ID: 12852863
[TBL] [Abstract][Full Text] [Related]
2. Protein transport across the in vitro perfused human placenta.
Malek A; Sager R; Lang AB; Schneider H
Am J Reprod Immunol; 1997 Oct; 38(4):263-71. PubMed ID: 9352013
[TBL] [Abstract][Full Text] [Related]
3. Abciximab (ReoPro, chimeric 7E3 Fab) demonstrates equivalent affinity and functional blockade of glycoprotein IIb/IIIa and alpha(v)beta3 integrins.
Tam SH; Sassoli PM; Jordan RE; Nakada MT
Circulation; 1998 Sep; 98(11):1085-91. PubMed ID: 9736595
[TBL] [Abstract][Full Text] [Related]
4. M281, an anti-FcRn antibody, inhibits IgG transfer in a human ex vivo placental perfusion model.
Roy S; Nanovskaya T; Patrikeeva S; Cochran E; Parge V; Guess J; Schaeck J; Choudhury A; Ahmed M; Ling LE
Am J Obstet Gynecol; 2019 May; 220(5):498.e1-498.e9. PubMed ID: 30849355
[TBL] [Abstract][Full Text] [Related]
5. Transport of immunoglobulin G and its subclasses across the in vitro-perfused human placenta.
Malek A; Sager R; Zakher A; Schneider H
Am J Obstet Gynecol; 1995 Sep; 173(3 Pt 1):760-7. PubMed ID: 7573239
[TBL] [Abstract][Full Text] [Related]
6. Human placental transport of oxytocin.
Malek A; Blann E; Mattison DR
J Matern Fetal Med; 1996; 5(5):245-55. PubMed ID: 8930795
[TBL] [Abstract][Full Text] [Related]
7. A new recycling technique for human placental cotyledon perfusion: application to studies of the fetomaternal transfer of glucose, inulin, and antipyrine.
Brandes JM; Tavoloni N; Potter BJ; Sarkozi L; Shepard MD; Berk PD
Am J Obstet Gynecol; 1983 Aug; 146(7):800-6. PubMed ID: 6869452
[TBL] [Abstract][Full Text] [Related]
8. The GP IIb/IIIa inhibitor abciximab (ReoPro) decreases activation and interaction of platelets and leukocytes during in vitro cardiopulmonary bypass simulation.
Straub A; Wendel HP; Azevedo R; Ziemer G
Eur J Cardiothorac Surg; 2005 Apr; 27(4):617-21. PubMed ID: 15784360
[TBL] [Abstract][Full Text] [Related]
9. The long-term clinical results of a platelet glycoprotein IIb/IIIa receptor blocker (Abciximab: Reopro) coated stent in patients with coronary artery disease.
Kim W; Jeong MH; Hong YJ; Lee SH; Park WS; Kim JH; Kim IS; Choi MJ; Ahn YK; Cho JG; Park JC; Cho DL; Kim H; Kang JC
Korean J Intern Med; 2004 Dec; 19(4):220-9. PubMed ID: 15683110
[TBL] [Abstract][Full Text] [Related]
10. Impact of cocaine on human placental function using an in vitro perfusion system.
Malek A; Ivy D; Blann E; Mattison DR
J Pharmacol Toxicol Methods; 1995 Aug; 33(4):213-9. PubMed ID: 8527829
[TBL] [Abstract][Full Text] [Related]
11. Expression of markers of platelet activation and the interpatient variation in response to abciximab.
Bihour C; Durrieu-Jaïs C; Macchi L; Poujol C; Coste P; Besse P; Nurden P; Nurden AT
Arterioscler Thromb Vasc Biol; 1999 Feb; 19(2):212-9. PubMed ID: 9974400
[TBL] [Abstract][Full Text] [Related]
12. Assessing platelet and fibrinogen contribution to clot strength using modified thromboelastography in pregnant women.
Gottumukkala VN; Sharma SK; Philip J
Anesth Analg; 1999 Dec; 89(6):1453-5. PubMed ID: 10589626
[TBL] [Abstract][Full Text] [Related]
13. Transfer and metabolism of thyrotropin releasing hormone across the perfused human term placenta.
Bajoria R; Oteng-Ntim E; Fisk NM
J Clin Endocrinol Metab; 1996 Oct; 81(10):3476-82. PubMed ID: 8855788
[TBL] [Abstract][Full Text] [Related]
14. Uptake and fate of exogenous immunoglobulin G in the perfused human placenta.
Contractor SF; Eaton BM; Stannard PJ
J Reprod Immunol; 1983 Sep; 5(5):265-73. PubMed ID: 6631834
[TBL] [Abstract][Full Text] [Related]
15. In vitro evaluation of c7E3-Fab (ReoPro) eluting polymer-coated coronary stents.
Baron JH; Gershlick AH; Hogrefe K; Armstrong J; Holt CM; Aggarwal RK; Azrin M; Ezekowitz M; de Bono DP
Cardiovasc Res; 2000 Jun; 46(3):585-94. PubMed ID: 10912469
[TBL] [Abstract][Full Text] [Related]
16. Activation of platelets in platelet-rich plasma by rotablation is speed-dependent and can be inhibited by abciximab (c7E3 Fab; ReoPro).
Williams MS; Coller BS; Väänänen HJ; Scudder LE; Sharma SK; Marmur JD
Circulation; 1998 Aug; 98(8):742-8. PubMed ID: 9727543
[TBL] [Abstract][Full Text] [Related]
17. Administration of abciximab during percutaneous coronary intervention reduces both ex vivo platelet thrombus formation and fibrin deposition: implications for a potential anticoagulant effect of abciximab.
Dangas G; Badimon JJ; Coller BS; Fallon JT; Sharma SK; Hayes RM; Meraj P; Ambrose JA; Marmur JD
Arterioscler Thromb Vasc Biol; 1998 Aug; 18(8):1342-9. PubMed ID: 9714143
[TBL] [Abstract][Full Text] [Related]
18. Role of transferrin in iron transport between maternal and fetal circulations of a perfused lobule of human placenta.
Contractor SF; Eaton BM
Cell Biochem Funct; 1986 Jan; 4(1):69-74. PubMed ID: 3943149
[TBL] [Abstract][Full Text] [Related]
19. Platelet glycoprotein IIb/IIIa antagonists: lessons learned from clinical trials and future directions.
Leclerc JR
Crit Care Med; 2002 May; 30(5 Suppl):S332-40. PubMed ID: 12004256
[TBL] [Abstract][Full Text] [Related]
20. Placental transport of immunoglobulin G.
Simister NE
Vaccine; 2003 Jul; 21(24):3365-9. PubMed ID: 12850341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
